American Society of Hypertension 22nd Annual Meeting and Exposition (ASH)

American Society of Hypertension 22nd Annual Meeting and Exposition (ASH)

Conference News

Impaired Glycemic Control Reversible When Switching Off Diuretic-Based TherapyResults from a six-month extension study have shown that impairment in glycemic control after one year of diuretic-based combination treatment is reversible by switching to treatment not involving a diuretic, in this case, an ACE inhibitor and calcium-channel blocker.
Heartwire, May 25, 2007

Combination Therapy With ARB and Amlodipine Effectively Reduces Blood PressureTwo new studies presented this week suggest that fixed-dose combination therapy with amlodipine and an angiotensin receptor blocker, either valsartan or olmesartan, can achieve significant reductions of blood pressure without an increase in serious adverse events.
Heartwire, May 24, 2007

ACCOMPLISH at 18 Months: Better Blood-Pressure Control With Single-Tablet Combination TherapyInterim data from the ACCOMPLISH study has shown that a single-tablet dual-mechanism therapy initiated in high-risk hypertensive patients is highly effective in reducing blood pressure and significantly better in getting more patients to treatment goals. While some see combination drugs as the wave of the future, others are concerned about going too fast in some patients.
Heartwire, May 22, 2007

Novel ARB Provides Greater Reductions in Proteinuria in Diabetics With Overt NephropathyOne year of treatment with telmisartan provided greater reductions in proteinuria when compared with losartan. The greater protection was not attributed to differences in blood pressure, and the antiproteinuric effects were sustained with telmisartan two months after therapy was stopped.
Heartwire, May 22, 2007

CAMELOT: Obese Patients Benefit the Most From Intensive Antihypertensive Drug TherapyAn analysis of the CAMELOT study has shown that the clinical benefits of intensive antihypertensive therapy in CAD patients is greatest in those considered obese, despite the fact that blood-pressure reductions were lower for obese patients than for lean or overweight patients.
Heartwire, May 21, 2007

Diet of Hypertensive Adults Is Getting Worse: Just 22% Following the DASH DietMore and more Americans are losing out in their mad DASH to good eating habits. A new study reveals that the dietary quality of hypertensive adults has deteriorated since the DASH diet became part of the national guidelines.
Heartwire, May 21, 2007